Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer

This study is currently recruiting participants.

Verified October 2012 by National Cancer Institute (NCI)

Sponsor:

Collaborators:

National Cancer Institute (NCI)

Radiation Therapy Oncology Group

Southwest Oncology Group

Information provided by:

National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:

NCT00103181

First received: February 7, 2005

Last updated: October 7, 2012

Last verified: October 2012

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	June 2015 (Final data collection date for primary outcome measure)

Publications:

Jain AK, Vallow LA, Gale AA, Buskirk SJ. Does Three-Dimensional External Beam Partial Breast Irradiation Spare Lung Tissue Compared with Standard Whole Breast Irradiation? Int J Radiat Oncol Biol Phys. 2009 Feb 19; [Epub ahead of print]

Tendulkar RD, Chellman-Jeffers M, Rybicki LA, Rim A, Kotwal A, Macklis R, Obi BB. Preoperative breast magnetic resonance imaging in early breast cancer: implications for partial breast irradiation. Cancer. 2009 Feb 17; [Epub ahead of print]

Patel RR, Christensen ME, Hodge CW, Adkison JB, Das RK. Clinical outcome analysis in "high-risk" versus "low-risk" patients eligible for national surgical adjuvant breast and bowel B-39/radiation therapy oncology group 0413 trial: five-year results. Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):970-3.

Al-Hallaq H, Mell L, Advani S, et al.: Magnetic resonance imaging (MRI) identifies multifocal and multicentric disease in breast cancer patients eligible for the NSABP B-39/RTOG 0413 partial breast irradiation (PBI) trial. [Abstract] Int J Radiat Oncol Biol Phys 66 (3 Suppl 1): A-1086, S179-S180, 2006.

To Top